(Q44413970)

English

A randomized trial of postoperative UFT therapy in p stage I, II non-small cell lung cancer: North-east Japan Study Group for Lung Cancer Surgery

scientific article published on May 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

A randomized trial of postoperative UFT therapy in p stage I, II non-small cell lung cancer: North-east Japan Study Group for Lung Cancer Surgery (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

1 reference

based on heuristic

inferred from title

Lung cancer surgery

1 reference

based on heuristic

inferred from title

1 reference

10.1016/S0169-5002(03)00032-1

https://api.crossref.org/works/10.1016/S0169-5002(03)00032-1

27 December 2023

author name string

Chiaki Endo

1

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Yasuki Saito

2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Hiroshi Iwanami

3

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Takao Tsushima

4

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Tadashi Imai

5

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Mitsuo Kawamura

6

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Takashi Kondo

7

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Kaoru Koike

8

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Masashi Handa

9

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Ryuzo Kanno

10

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Shigefumi Fujimura

11

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

North-east Japan Study Group for Lung Cancer Surgery

12

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12711119

27 December 2023

publication date

1 May 2003

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S0169500203000321?httpAccept=text/xml

1 reference

10.1016/S0169-5002(03)00032-1

https://api.crossref.org/works/10.1016/S0169-5002(03)00032-1

27 December 2023

https://api.elsevier.com/content/article/PII:S0169500203000321?httpAccept=text/plain

1 reference

10.1016/S0169-5002(03)00032-1

https://api.crossref.org/works/10.1016/S0169-5002(03)00032-1

27 December 2023

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

40

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

181-186

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Adjuvant chemotherapy after complete resection in non-small-cell lung cancer. West Japan Study Group for Lung Cancer Surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900032-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Postoperative adjuvant chemotherapy with PVM (Cisplatin + Vindesine + Mitomycin C) and UFT (Uracil + Tegaful) in resected stage I-II NSCLC (non-small cell lung cancer): a randomized clinical trial. West Japan Study Group for lung cancer surgery (WJS

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900032-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant chemotherapy after radical surgery for non-small-cell lung cancer: a randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900032-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Surgical adjuvant therapy for stage II and stage III adenocarcinoma and large-cell undifferentiated carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900032-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant chemo-immunotherapy after curative resection of Stage II and IIIA primary lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900032-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The benefit of adjuvant treatment for resected locally advanced non-small-cell lung cancer. The Lung Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900032-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant chemotherapy with cyclophosphamide, doxorubicin, and cisplatin in patients with completely resected stage I non-small-cell lung cancer. The Lung Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900032-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Postoperative adjuvant chemotherapy in non-small cell lung cancer: prognostic value of DNA ploidy and post-recurrent survival

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900032-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant radiotherapy versus combined sequential chemotherapy followed by radiotherapy in the treatment of resected nonsmall cell lung carcinoma. A randomized trial of 267 patients. GETCB (Groupe d'Etude et de Traitement des Cancers Bronchiques).

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900032-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial comparing postoperative chemotherapy with vindesine and cisplatin plus thoracic irradiation with irradiation alone in stage III (N2) non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900032-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Postoperative adjuvant therapy for stage II non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900032-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0169-5002(03)00032-1

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44413970&oldid=2037944930"